You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Uric acid transporter 1 (URAT1) Inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gout Trial (ABP-671, Allopurinol, Placebo)

Not yet recruiting
  • Gout
  • (no location specified)
Apr 5, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Tumor Lysis Syndrome Trial in Houston (Pegloticase, Rasburicase)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Type 1 Diabetes, Diabetic Nephropathy, Diabetic Kidney Disease Trial in Aurora (sodium bicarbonate)

Completed
Has Results
  • Type 1 Diabetes
  • +2 more
  • sodium bicarbonate
  • Aurora, Colorado
    Barbara Davis Center for Diabetes
Jan 14, 2022

Kidney Transplant Recipients Trial in Toronto (Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL)

Not yet recruiting
  • Kidney Transplant Recipients
  • Dapagliflozin 10 MG
  • Semaglutide, 1.0 mg/mL
  • Toronto, Ontario, Canada
    Toronto General Hospital
Jul 6, 2023

Solid Tumors Trial in Bruxelles, Wilrijk (BI 907828, Rifampicin)

Recruiting
  • Solid Tumors
  • Bruxelles, Belgium
  • +4 more
Jan 9, 2023

Uric Acid, Cardiovascular Diseases, Gout Trial in Sheffield (Tart cherry juice, Water)

Recruiting
  • Uric Acid
  • +2 more
  • Tart cherry juice
  • Water
  • Sheffield, United Kingdom
    Food and Nutrition Group, Sheffield Hallam University
Jul 14, 2021

Health Services Research Trial in College Station (Placebo, Active)

Recruiting
  • Health Services Research
  • Placebo
  • Active
  • College Station, Texas
    Exercise & Sport Nutrition Lab - Human Clinical Research Facilit
Oct 4, 2021

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

Recruiting
  • Hypertension
  • +17 more
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Jan 3, 2023

    Healthy Trial in Brussels (Sisunatovir, Rabeprazole)

    Not yet recruiting
    • Healthy
    • Brussels, Bruxelles-capitale, Région DE, Belgium
      Pfizer Clinical Research Unit - Brussels
    Oct 24, 2023

    Diabetes Trial in Gières (Sotagliflozin (SAR439954), Mefenamic acid)

    Completed
    • Diabetes Mellitus
    • Sotagliflozin (SAR439954)
    • Mefenamic acid
    • Gières, France
      Investigational site 250001
    Apr 21, 2022

    Adult Solid Tumor, Diffuse Large B Cell Lymphoma, Burkitt Lymphoma Trial in United Kingdom (AZD3965)

    Completed
    Has Results
    • Adult Solid Tumor
    • +2 more
    • Sutton, London, United Kingdom
    • +6 more
    Feb 10, 2022

    Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma

    Recruiting
    • Refractory Thyroid Gland Carcinoma
    • +3 more
    • 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
    • +2 more
    • Xiamen, China
      The First Affiliated Hospital of Xiamen University
    Nov 3, 2022

    Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

    Not yet recruiting
    • Localized Osteosarcoma
    • +3 more
    • Cabozantinib S-malate
    • +7 more
    • (no location specified)
    Jan 4, 2023

    Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

    Active, not recruiting
    • Primary Myelofibrosis
    • Secondary Myelofibrosis
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +11 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 10, 2023

    Serum Uric Acid and Metabolic Syndrome in Type 2 DM

    Not yet recruiting
    • Metabolic Syndrome
    • Serum uric acid levels ,HBA1C , fasting plasma glucose ,lipid profile , creatinine level
    • (no location specified)
    Sep 29, 2020

    Type 2 Diabetes Trial in Amsterdam (Empagliflozin 25 MG, Benzbromaron, Empagliflozin 25 MG + benzbromarone 100 mg)

    Completed
    • Type 2 Diabetes
    • Empagliflozin 25 MG
    • +2 more
    • Amsterdam, Noord-Holland, Netherlands
      VU University Medical Center
    Jan 13, 2022

    Alagille Syndrome Trial in Birmingham, Leeds, London (LUM001 (Maralixibat))

    Completed
    Has Results
    • Alagille Syndrome
    • LUM001 (Maralixibat)
    • Birmingham, West Midlands, United Kingdom
    • +2 more
    Nov 17, 2021

    Uric Acid Nephropathy Trial in Caba (Losartan Potassium)

    Recruiting
    • Uric Acid Nephropathy
    • Losartan Potassium
    • Caba, Argentina
      HGNPE
    Nov 24, 2022

    Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)

    Completed
    • Fallopian Tube Carcinoma
    • +2 more
    • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2021

    Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

    Not yet recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • Locally Advanced Pancreatic Ductal Adenocarcinoma
    • Biospecimen Collection
    • +9 more
    • Los Angeles, California
      Yonemoto,Lisa
    Jan 13, 2023

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States

    Suspended
    • Acute Myeloid Leukemia
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • Los Angeles, California
    • +5 more
    Dec 10, 2022

    Uric Acid Based Renal Stones: Clinical, Metabolic and Genetic

    Recruiting
    • Renal Stone
    • Urinary Stones
      • Mansoura, DK, Egypt
        Urology and nephrology center
      Nov 22, 2022

      Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +

      Recruiting
      • Colorectal Cancer
      • +4 more
      • NUC-3373 + leucovorin
      • +8 more
      • Boston, Massachusetts
      • +9 more
      Jan 23, 2023

      Hyperuricemia Trial in Jinhua (Study Product A (High-dose 2X), Study Product B (Low-dose X), Placebo)

      Recruiting
      • Hyperuricemia
      • Study Product A (High-dose 2X)
      • +2 more
      • Jinhua, Zhejiang, China
        Charlie Zhang
      Oct 10, 2023

      Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III

      Terminated
      • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
      • +9 more
      • Bintrafusp Alfa
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 4, 2022